GLABFGEMINA LABORATORIES LTD.

About GEMINA LABORATORIES LTD. (GLABF)

GEMINA LABORATORIES LTD. (GLABF) is a Biotechnology company headquartered in Burnaby, BC, Canada whose shares trade over-the-counter on the OTCQB tier.

Gemina Labs has developed and patented a transformative bio-chemistry that powers next-generation testing platforms for detecting a wide range of pathogens that affect humans and animals. Our tests are fast, affordable and accurate, and easily self-administered providing consumers with direct solutions where they need them.

Products and services

Gemina Laboratories is a chemistry platform that creates diagnostic tests focused on infectious respiratory diseases.

GLABF key facts

Ticker symbol

GLABF

Market tier

OTCQB

Sector

Healthcare

Industry

Biotechnology

Headquarters

Burnaby, BC, Canada

Country of incorporation

CA

Year of incorporation

2017

Employees

6

Estimated market cap

$70.30M (as of Apr 11, 2025)

Shares outstanding

76,460,333

Reporting standard

International Reporting: Canadian Securities Exchange

Audit status

Audited

Fiscal year end

1/31

Latest filing

Quarterly Report (Oct 31, 2024)

GEMINA LABORATORIES LTD. leadership

• Brian Firth — CEO
• Michael Liggett — CFO
• Rob Greene — CTO
• LeAnn Mogerman — Controller
• Allison Kaufman — Other

Explore more: Biotechnology stocks · Healthcare sector · OTCQB stocks · OTC stocks starting with G